Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.3860
+0.0360 (10.29%)
Jun 27, 2025, 5:25 PM CET

Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €15.99 million as of June 27, 2025. Its market cap has increased by 24.92% in one year.

Market Cap
15.99M
Enterprise Value
12.70M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.39

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 15.99M, a decrease of -84.32%. That is a compound annual growth rate of -14.35%.

History

DateMarket Cap% Change
Jun 18, 202516.32M-44.66%
Dec 31, 202429.50M82.56%
Dec 29, 202316.16M41.33%
Dec 30, 202211.43M-85.60%
Dec 31, 202179.42M-13.96%
Dec 31, 202092.30M-31.75%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
UCB SA 29.49B
argenx SE 28.87B
Financière de Tubize 5.56B
Fagron NV 1.64B
Ion Beam Applications 340.08M
Nyxoah 242.15M
Onward Medical 197.33M
Hyloris Pharmaceuticals 173.60M
Market Cap Rankings